Literature DB >> 8973570

p30, a novel protein target of mouse calcyclin (S100A6).

A Filipek1, U Wojda.   

Abstract

A novel protein target of mouse calcyclin (S100A6) was detected by a gel overlay method with 125I-labelled calcyclin. Interaction of calcyclin with its 30 kDa target protein (p30) present in Ehrlich ascites tumour (EAT) cells depended on the presence of Ca2+ ions. The binding of p30, evidenced by the reaction with 125I-labelled calcyclin, was found to be of higher affinity than the binding between mouse calcyclin and annexin II or glyceraldehyde-3-phosphate dehydrogenase. Examination of tissue extracts by the gel overlay method has shown that p30 is present not only in the EAT cells but also in mouse brain and spleen. This novel target protein of mouse calcyclin was purified to homogeneity from EAT cells by means of Phenyl-Sepharose chromatography, affinity chromatography and CM-cellulose chromatography. Purified p30 was digested with alpha-chymotrypsin and a partial amino acid sequence of one of the resulting peptides was established. A database search analysis revealed that the sequence is unique, with a similarity of less than 55% to any other known protein sequence.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8973570      PMCID: PMC1217969          DOI: 10.1042/bj3200585

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Calcium-binding protein from mouse Ehrlich ascites-tumour cells is homologous to human calcyclin.

Authors:  J Kuźnicki; A Filipek; P E Hunziker; S Huber; C W Heizmann
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Calcyclin--from basic research to clinical implications.

Authors:  A Filipek; J Kuźnicki
Journal:  Acta Biochim Pol       Date:  1993       Impact factor: 2.149

5.  Identification of annexin II, annexin VI and glyceraldehyde-3-phosphate dehydrogenase as calcyclin-binding proteins in bovine heart.

Authors:  F Y Zeng; V Gerke; H J Gabius
Journal:  Int J Biochem       Date:  1993-07

6.  Molecular cloning of rabbit CAP-50, a calcyclin-associated annexin protein.

Authors:  H Tokumitsu; A Mizutani; M Muramatsu; T Yokota; K Arai; H Hidaka
Journal:  Biochem Biophys Res Commun       Date:  1992-08-14       Impact factor: 3.575

7.  A calcyclin-associated protein is a newly identified member of the Ca2+/phospholipid-binding proteins, annexin family.

Authors:  H Tokumitsu; A Mizutani; H Minami; R Kobayashi; H Hidaka
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

8.  A calcium-binding protein from rabbit lung cytosol identified as the product of growth-regulated gene (2A9) and its binding proteins.

Authors:  H Tokumitsu; R Kobayashi; H Hidaka
Journal:  Arch Biochem Biophys       Date:  1991-07       Impact factor: 4.013

9.  Characterization of the cell-cycle-regulated protein calcyclin from Ehrlich ascites tumor cells. Identification of two binding proteins obtained by Ca2(+)-dependent affinity chromatography.

Authors:  A Filipek; V Gerke; K Weber; J Kuźnicki
Journal:  Eur J Biochem       Date:  1991-02-14

Review 10.  The S100 protein family: history, function, and expression.

Authors:  D B Zimmer; E H Cornwall; A Landar; W Song
Journal:  Brain Res Bull       Date:  1995       Impact factor: 4.077

View more
  12 in total

1.  CacyBP/SIP expression is involved in the clinical progression of breast cancer.

Authors:  Ningju Wang; Qingyong Ma; Yinna Wang; Gang Ma; Huihong Zhai
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

2.  Identification and characterization of a novel calcyclin binding protein (CacyBP) gene from Apis cerana cerana.

Authors:  Xiaoli Yu; Wenjing Lu; Rujiang Sun; Xingqi Guo; Baohua Xu
Journal:  Mol Biol Rep       Date:  2012-04-27       Impact factor: 2.316

Review 3.  Calcium-dependent and -independent interactions of the S100 protein family.

Authors:  Liliana Santamaria-Kisiel; Anne C Rintala-Dempsey; Gary S Shaw
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

Review 4.  The potential role of CacyBP/SIP in tumorigenesis.

Authors:  Xiaoxuan Ning; Yang Chen; Xiaosu Wang; Qiaoneng Li; Shiren Sun
Journal:  Tumour Biol       Date:  2016-02-13

5.  Dimerization and phosphatase activity of calcyclin-binding protein/Siah-1 interacting protein: the influence of oxidative stress.

Authors:  Agnieszka M Topolska-Woś; Steven M Shell; Ewa Kilańczyk; Roman H Szczepanowski; Walter J Chazin; Anna Filipek
Journal:  FASEB J       Date:  2015-01-21       Impact factor: 5.191

6.  Age-dependent changes in neuronal distribution of CacyBP/SIP: comparison to tubulin and the tau protein.

Authors:  Anna Filipek; Gabriela Schneider; Anna Mietelska; Izabela Figiel; Grazyna Niewiadomska
Journal:  J Neural Transm (Vienna)       Date:  2008-05-28       Impact factor: 3.575

7.  Calcyclin Binding Protein/Siah-1 Interacting Protein Is a Hsp90 Binding Chaperone.

Authors:  Agnieszka Góral; Paweł Bieganowski; Wiktor Prus; Łucja Krzemień-Ojak; Beata Kądziołka; Hanna Fabczak; Anna Filipek
Journal:  PLoS One       Date:  2016-06-01       Impact factor: 3.240

Review 8.  S100A6 and Its Brain Ligands in Neurodegenerative Disorders.

Authors:  Anna Filipek; Wiesława Leśniak
Journal:  Int J Mol Sci       Date:  2020-06-01       Impact factor: 5.923

9.  Downregulation of CacyBP by CRISPR/dCas9-KRAB Prevents Bladder Cancer Progression.

Authors:  Hanxiong Zheng; Chiheng Chen
Journal:  Front Mol Biosci       Date:  2021-06-11

10.  Expression of S100A6 in rat hippocampus after traumatic brain injury due to lateral head acceleration.

Authors:  Bo Fang; Ming Liang; Guitao Yang; Yuqin Ye; Hongyu Xu; Xiaosheng He; Jason H Huang
Journal:  Int J Mol Sci       Date:  2014-04-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.